Antitussives that contain codeine are classified under which schedule?

Antitussives that contain codeine are classified under Schedule V due to the specific regulations governing their use and distribution. Schedule V substances are recognized for having a lower potential for abuse compared to those classified in higher schedules.

In the case of codeine-containing antitussives, they are often formulated with concentrations of codeine that fall within the acceptable limits established by the Drug Enforcement Administration (DEA) for Schedule V drugs. For example, a common formulation might contain only a small amount of codeine, and when combined with other non-narcotic ingredients, it can be dispensed without a prescription in some states, further highlighting the controlled yet relatively low risk associated with their use.

This classification allows for the medicinal use of codeine for treating coughs while maintaining regulatory oversight to prevent misuse. Understanding this scheduling is critical for pharmacy practice, as it influences how these medications can be prescribed and dispensed to patients.